NEUROONE MEDICAL TECHNOLOGIES Corp·4

Nov 14, 5:30 PM ET

Volker Christopher 4

4 · NEUROONE MEDICAL TECHNOLOGIES Corp · Filed Nov 14, 2023

Insider Transaction Report

Form 4
Period: 2023-11-10
Volker Christopher
Chief Operating Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2023-11-10+324,560324,560 total
    Exercise: $1.32Exp: 2033-11-09Common Stock (324,560 underlying)
Footnotes (1)
  • [F1]25% will vest on November 10, 2024, and the remaining 75% will vest in 36 equal monthly installments on the last day of each month following November 10, 2024.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT